| Name | Title | Contact Details |
|---|---|---|
Kelly Brown |
Interim Associate Dean and Chief Information Officer | Profile |
Uduak Ndoh |
Chief Information Officer and Associate Dean for Information Technology | Profile |
The American College of Gastroenterology is a professional organization with an international membership of over 17,000 individuals from 86 countries. The College provides its members with the most accurate and up to date scientific information on dige...
Holistic training, health and retirement benefits for Washington states professional home caregivers.
MetaOptima: empowering users with advanced technologies MetaOptima is a digital health tech company dedicated to revolutionizing the dermatology and skin care industry with affordable, effective and intelligent tools. In order to provide state-of-the-art care, both medical professionals and their patients should be equipped with advanced tools. We are proud to offer two products designed to enhance the quality of patient care and organization while streamlining services for maximum efficiency: DermEngine and MoleScope. DermEngine is an intelligent skin analytics platform designed to provide medical experts with smart technologies to enhance workflows, organization and communications. MoleScope is a digital dermoscopic attachment for smartphones/tablets that allows users to take medical grade quality images of their skin. Here at MetaOptima, we take pride in our bold vision to bring digital healthcare and mobile technologies together to save lives and contribute to better health outcomes. We work hard to build a successful company with strong values and sense of community, as well as create jobs and develop tools that make the world a better place for patients, doctors, and businesses.
Gennev is a virtual care provider for women in menopause, offering telehealth doctors, health coaches, products, and education to help women feel 100% again.
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing and commercializing a portfolio of large volume ready-to-use infusible pharmaceuticals. Our vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via our proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. Our infusion platform is intended to address some of the most pressing unmet needs in infusion today: cost, medication error, sterility, efficiency, and patient quality of life.